Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

TNXPTNXP
6 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in TONIX PHARMACEUTICALS HLDG C

NORTHERN TRUST CORP holds 120,386 shares of TNXP (TONIX PHARMACEUTICALS HLDG C), worth $1.5M as of 2026-Q2. The position was increased (+20.2% shares). TNXP represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$1.5M

Current Shares

120,386

Total Value Change

+$1.3M

Total Shares Change

+107,318

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
120,386
+20.2%
$1.5M0.0%$12.76
30
2026-Q1
Decreased
100,134
-42.7%
$1.4M0.0%$13.94
0
2025-Q4
Increased
174,886
+3.1%
$2.7M0.0%$15.82
27
2025-Q3
Increased
169,687
+3.5%
$4.1M0.0%$24.76
28
2025-Q2
Increased
164,022
+1155.1%
$5.9M0.0%$34.89
44
2025-Q1
New
13,068
-
$233,5910.0%$20.17
35

Other major holders of TNXP: BlackRock, Inc., Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used